Pharma and HealthcareCase Study: Does Branding Impact Sales?How OSG helped a global pharmaceutical company evaluate and prioritize potential scientific statements intended to launch an unbranded campaign to educate physicians before the launch of Drug X.A global pharmaceutical company and its agency of record were planning to launch an unbranded campaign to shape the opioid-Induced nausea and vomiting (OINV) treatment market for the later launch of Drug X and thus wanted to test potential scientific statements that would boost this campaign. Using Dynamo, OSG’s AI-driven big data analytics platform, OSG conducted research in the United States to prioritize messages designed to launch a campaign that educates physicians about OINV and drives them to seek more information.Download Case Study - Unbranded Message Testing for a Global Pharmaceutical CompanyCheck out more of our case studies:Case Study: Subscribing for Better StrategyHow OSG helped a streaming subscription service strategize its pricing and content to reach a wider audience base through targeted needs-based actions.Read moreCase Study: Reception of Targeted MessagingHow OSG helped a global hotel chain reach target audiences through its messaging strategy, to maintain and build their customer base.Read more